Malta 2017: MMA-EURORDIS-COMP-IMI Conference

Ralf-Dieter Hilgers is representing IDeAl, and disseminating the IDeAl results at the MMA-EURORDIS-COMP-IMI Conference in Malta this week. As an invited speaker, he seized the chance to present “Innovative statistical design methodologies for clinical trials in small populations focussing on rare diseases“.  This conference, organized during the Maltese Presidency aims at discussing the development of medicinal products for rare diseases. It brings together the European Organisation for Rare Diseases (EURORDIS), EU Health Ministers, experts from the Committee of Orphan Medicinal Products (COMP) and the members of the Innovative Medicines Initiative (IMI), and provides an IDeAl forum for disseminating our results to the regulators of the day.